We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
-7.03%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$446M
AUM Growth
-$188M
Cap. Flow
-$138M
Cap. Flow %
-31.01%
Top 10 Hldgs %
45.39%
Holding
194
New
46
Increased
33
Reduced
32
Closed
61

Top Sells

Rank Stock Value
1
CTLP
Cantaloupe
CTLP
+$32.7M
2
ELV icon
Elevance Health
ELV
+$26.7M
3
AMD icon
Advanced Micro Devices
AMD
+$7.95M
4
ADBE icon
Adobe
ADBE
+$7.66M
5
XLNX
Xilinx Inc
XLNX
+$7.6M

Sector Composition

Rank Sector Weight
1 Technology 28.57%
2 Industrials 14.77%
3 Healthcare 13.92%
4 Consumer Discretionary 8.46%
5 Utilities 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTNT
101
DELISTED
Quotient Limited Ordinary Shares
QTNT
$389K 0.09%
1,250
CLNE icon
102
Clean Energy Fuels
CLNE
$421M
$361K 0.08%
175,000
+75,000
+75% +$174K
SONY icon
103
Sony
SONY
$133B
$355K 0.08%
30,000
-10,000
-25% -$113K
TNDM icon
104
Tandem Diabetes Care
TNDM
$1.22B
$354K 0.08%
6,000
DIS icon
105
PUT
Walt Disney
DIS
$172B
$352K 0.08%
+2,700
New +$373K
BE icon
106
Bloom Energy
BE
$47.5B
$325K 0.07%
100,000
+55,000
+122% +$411K
GLNG icon
107
Golar LNG
GLNG
$4.95B
$325K 0.07%
+25,000
New +$367K
RVLV icon
108
Revolve Group
RVLV
$1.92B
$304K 0.07%
+13,000
New +$371K
ZUO
109
DELISTED
Zuora, Inc.
ZUO
$301K 0.07%
+20,000
New +$301K
MSFT icon
110
PUT
Microsoft
MSFT
$2.92T
$278K 0.06%
+2,000
New +$275K
ALDX icon
111
Aldeyra Therapeutics
ALDX
$95.3M
$248K 0.06%
47,100
TUSK icon
112
Mammoth Energy Services
TUSK
$125M
$248K 0.06%
+100,000
New +$475K
ALXN
113
DELISTED
Alexion Pharmaceuticals
ALXN
$245K 0.05%
2,500
-2,500
-50% -$282K
HEXO
114
DELISTED
HEXO Corp. Common Shares
HEXO
$238K 0.05%
+1,071
New +$267K
SIEN
115
DELISTED
Sientra, Inc.
SIEN
$194K 0.04%
3,000
+300
+11% +$19.1K
APEN
116
DELISTED
Apollo Endosurgery, Inc.
APEN
$165K 0.04%
50,188
+1,500
+3% +$4.75K
AMD icon
117
PUT
Advanced Micro Devices
AMD
$741B
$159K 0.04%
+5,500
New +$172K
HROW icon
118
Harrow
HROW
$1.47B
$141K 0.03%
25,000
-40,000
-62% -$262K
CSTM icon
119
Constellium
CSTM
$3.96B
$127K 0.03%
+10,000
New +$118K
GNLN icon
120
Greenlane Holdings
GNLN
$1.13M
0
VATE icon
121
INNOVATE Corp
VATE
$106M
$118K 0.03%
5,000
VIA
122
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$106K 0.02%
2,000
-5,000
-71% -$264K
CBAY
123
DELISTED
Cymabay Therapeutics
CBAY
$102K 0.02%
20,000
NEPT
124
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$89K 0.02%
18
BSX icon
125
PUT
Boston Scientific
BSX
$68.5B
$81K 0.02%
+2,000
New +$84.7K

Similar funds

Ardsley Advisory Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Ardsley Advisory Partners held 194 positions worth $446M, down 30% from $634M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Ardsley Advisory Partners withdrew a net $138M in Q3 2019, closing 61 positions and reducing 32 holdings. Its most notable exit was Cantaloupe, an estimated $32.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Ardsley Advisory Partners opened a new position in Alibaba worth $13.4M.

  • Ardsley Advisory Partners's largest Q3 2019 buy was Alibaba: 80,250 shares worth $13.4M.
  • Ardsley Advisory Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019, an estimated $17.1M increase.
  • Ardsley Advisory Partners's biggest Q3 2019 reduction was Advanced Micro Devices, cutting an estimated $7.95M.
  • Ardsley Advisory Partners fully exited Cantaloupe in Q3 2019, selling an estimated $32.7M.
  • Ardsley Advisory Partners's ten largest holdings make up 45% of its $446M portfolio in Q3 2019.
  • Ardsley Advisory Partners opened 46 new positions and closed 61 in Q3 2019.
  • Ardsley Advisory Partners's portfolio value fell 30% quarter-over-quarter to $446M.

Based on Ardsley Advisory Partners's 13F filing for Q3 2019, filed 14 Nov 2019.